NCT00346424View on ClinicalTrials.gov

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
ThrombosisVenous Thrombosis
Interventions
DRUG

Alfimeprase

Trial Locations (1)

97330

Corvallis Clinic, Corvallis

Sponsors
All Listed Sponsors
lead

ARCA Biopharma, Inc.

INDUSTRY

NCT00346424 - Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters | Biotech Hunter | Biotech Hunter